Cancer Cause and Prevention Research in Georgia
Cancer Cause and Prevention Research (93.393) awarded $61.3 million to recipients in Georgia in 50 grants from fiscal 2021 to 2025, 1.7% of the program's national total. Emory University received the most, $49.5 million.
- Awarded in Georgia$61.3 million
- Awards50
- Share of the program1.7%
- Rank among states14th of 48
- National total$3.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 25 | $11.4 million |
| FY 2022 | 28 | $13.8 million |
| FY 2023 | 27 | $13.4 million |
| FY 2024 | 25 | $12.4 million |
| FY 2025 | 25 | $10.3 million |
Recipients in Georgia
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Emory University | Colleges and universities | 42 | $49.5 million |
| Georgia State University Research Foundation Inc | Colleges and universities | 5 | $7.4 million |
| Augusta University Research Institute, Inc | Nonprofits | 2 | $2.6 million |
| The Morehouse School of Medicine, Inc. | Other | 1 | $1.7 million |
Open opportunities under this program
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
- Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 58 on the program page
Questions people ask
How much Cancer Cause and Prevention Research money goes to Georgia?
$61.3 million from fiscal 2021 to 2025, across 50 awards. Georgia ranks 14th of 48 states and territories for this program.
Who receives Cancer Cause and Prevention Research money in Georgia?
The largest recipient is Emory University, with $49.5 million in 42 awards. Next are Georgia State University Research Foundation Inc and Augusta University Research Institute, Inc.
Can organizations in Georgia apply now?
Yes, 58 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Cause and Prevention Research in other states
Other large programs in Georgia
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- 1332 State Innovation Waivers
- Children's Health Insurance Program
- Special Education Grants to States
- Temporary Assistance for Needy Families